Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Treatment of high risk Sertoli-Leydig cell tumors of the ovary using a gonadotropin releasing hormone (GnRH) analog.

Lashkari HP, Nash R, Albanese A, Okoye B, Millar R, Pritchard-Jones K.

Pediatr Blood Cancer. 2013 Jun;60(6):E16-8. doi: 10.1002/pbc.24382. Epub 2012 Nov 28.

2.

Gonadotropin-releasing hormone-agonist as a neoadjuvant therapy for Sertoli-Leydig cell tumors of the ovary.

Chao HT, Wang PH, Lin HD.

Int J Gynaecol Obstet. 1999 Aug;66(2):189-90. No abstract available.

PMID:
10468350
3.

Metastatic Sertoli-Leydig cell ovarian cancer manifested as a frontal sinus mass.

Campisi P, Cheski P.

J Otolaryngol. 1998 Dec;27(6):361-2. No abstract available.

PMID:
9857323
4.

Recurrence of Sertoli-Leydig cell tumour in contralateral ovary. Case report and review of literature.

Latthe P, Shafi MI, Rollason TP.

Eur J Gynaecol Oncol. 2000;21(1):62-3. Review. No abstract available.

PMID:
10726622
5.

Ovarian sertoli-leydig cell tumors: A multicenter long-term clinicopathological analysis of 27 patients.

Akman L, Ertas IE, Gokcu M, Terek MC, Sanci M, Sanli UA, Zekioglu O, Ozsaran AA.

J Cancer Res Ther. 2016 Jan-Mar;12(1):290-4. doi: 10.4103/0973-1482.158037.

6.

Sertoli-Leydig cell tumor of the ovary: analysis of a single institution database.

Bhat RA, Lim YK, Chia YN, Yam KL.

J Obstet Gynaecol Res. 2013 Jan;39(1):305-10. doi: 10.1111/j.1447-0756.2012.01928.x. Epub 2012 Jun 13.

PMID:
22691037
7.

No rules without exception: a long-term complete remission observed in a study using a LH-RH agonist in platinum-refractory ovarian cancer.

Paskeviciute L, Roed H, Engelholm A.

Eur J Cancer. 2002 Nov;38 Suppl 6:S73. No abstract available.

PMID:
12409084
8.

The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.

Durieux E, Descotes F, Mauduit C, Decaussin M, Guyetant S, Devouassoux-Shisheboran M.

Virchows Arch. 2016 May;468(5):631-6. doi: 10.1007/s00428-016-1922-0. Epub 2016 Mar 16. Review.

PMID:
26983701
9.

Encouraging response of an advanced steroid-cell tumor to GnRH agonist therapy.

Brewer CA, Shevlin D.

Obstet Gynecol. 1998 Oct;92(4 Pt 2):661-3.

PMID:
9764654
10.
11.

Platinum based chemotherapy to treat recurrent Sertoli-Leydig cell ovarian carcinoma during pregnancy.

Tomlinson MW, Treadwell MC, Deppe G.

Eur J Gynaecol Oncol. 1997;18(1):44-6. Review. No abstract available.

PMID:
9061323
12.

A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors.

Gui T, Cao D, Shen K, Yang J, Zhang Y, Yu Q, Wan X, Xiang Y, Xiao Y, Guo L.

Gynecol Oncol. 2012 Nov;127(2):384-9. doi: 10.1016/j.ygyno.2012.07.114. Epub 2012 Jul 28.

PMID:
22850410
13.

Recurrent Sertoli-Leydig cell tumor of ovary in 8-year-old girl.

Turkyilmaz Z, Karabulut R, Ozbakir F, Pinarli G, Arda Inan M, Oguz A, Sonmez K.

Scott Med J. 2016 Feb;61(1):56-9. doi: 10.1177/0036933015619297. Epub 2016 Jun 22.

PMID:
27334531
14.

Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry.

Schultz KA, Pacheco MC, Yang J, Williams GM, Messinger Y, Hill DA, Dehner LP, Priest JR.

Gynecol Oncol. 2011 Aug;122(2):246-50. doi: 10.1016/j.ygyno.2011.03.024. Epub 2011 Apr 17.

15.

Bilateral ovarian well-differentiated Sertoli-Leydig cell tumors with heterologous elements associated with unilateral serous cystadenoma--a case report.

Stacher E, Pristauz G, Scholz HS, Moinfar F.

Int J Gynecol Pathol. 2010 Sep;29(5):419-22. doi: 10.1097/PGP.0b013e3181db69c7.

PMID:
20736765
16.

Leuprolide acetate in advanced ovarian serous tumor of low malignant potential. A case report.

Tresukosol D, Kudelka AP, Edwards CL, Silva EG, Kanojia M, Kavanagh JJ.

J Reprod Med. 1996 May;41(5):363-6.

PMID:
8725765
17.

Direct in-vivo detection of atypical hormonal expression of a Sertoli-Leydig cell tumour following stimulation with human chorionic gonadotrophin.

Cohen I, Shapira M, Cuperman S, Goldberger S, Siegal A, Altaras M, Beyth Y.

Clin Endocrinol (Oxf). 1993 Oct;39(4):491-5.

PMID:
8287578
18.

Sertoli-Leydig cell tumor of the ovary.

Chen FY, Sheu BC, Lin MC, Chow SN, Lin HH.

J Formos Med Assoc. 2004 May;103(5):388-91.

PMID:
15216408
19.

Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study.

Sigismondi C, Gadducci A, Lorusso D, Candiani M, Breda E, Raspagliesi F, Cormio G, Marinaccio M, Mangili G.

Gynecol Oncol. 2012 Jun;125(3):673-6. doi: 10.1016/j.ygyno.2012.03.024. Epub 2012 Mar 22.

PMID:
22446621
20.

Supplemental Content

Support Center